DiGeorge Anomaly: Clinical Trials

2 trials for DiGeorge Anomaly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow DiGeorge Anomaly: new trials by email Literature Review of DiGeorge Anomaly trials Research Report on DiGeorge Anomaly

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Thymus Transplantation With Immunosuppression #950
Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly
Phase 1 / Phase 2CompletedSumitomo Pharma Switzerland GmbH142005-12-192022-03-25
Thymus Transplantation With Immunosuppression
Thymus Tissue for Transplantation - DiGeorge Syndrome, DiGeorge Anomaly
Phase 1CompletedSumitomo Pharma Switzerland GmbH152002-07-012022-04-04

Narrower conditions

DiGeorge Syndrome (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Thymic aplasia (2)  ·  Hypocalcemia (1)  ·  Hypoparathyroidism (1)

Broader conditions

22q11 Deletion Syndrome (2)  ·  Abnormalities, Multiple (2)  ·  Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Chromosome Disorders (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Craniofacial Abnormalities (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Lymphatic Abnormalities (2)

Interventions

Antilymphocyte Serum (1)  ·  Blood Specimen Collection (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Daclizumab (1)  ·  Drug Implants (1)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Phlebotomy (1)  ·  Prednisolone (1)  ·  Steroids (1)  ·  Tacrolimus (1)  ·  Thymus Extracts (1)  ·  Transplantation (1)  ·  thymoglobulin (1)

Sponsors

Sumitomo Pharma Switzerland GmbH (2)

Countries

United States (2)

Top investigators

M. Louise Markert, MD, PhD (2)

Results publications

PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606, PMID 15100156, PMID 15100681, PMID 17284531, PMID 18155964, PMID 18333898, PMID 20978268, PMID 22590644

NIH funding

K12HD043494 (2), R01AI047040 (2), R01AI054843 (2), R56AI047040 (1)